There are several causes and clinical settings associated with the CB obliterans lesion ( Box 1). Idiopathic obliterative bronchiolitis disorder is rare and has been described in only a few case ...

Rationale and objectives Obliterative bronchiolitis (OB) is a rare disease with a small number of established occupational aetiologies. We describe a case series of severe OB in workers making ...

- BOSTON-3 is an open-label extension study of the pivotal trials in which eligible participants will receive L-CsA-i - BOSTON-4 is a safety and tolerability study of L‑CsA‑i in adults with BOS ...

Obliterative bronchiolitis (OB) is a serious long-term complication after bone marrow transplantation (BMT), and develops in about 10% of patients. 1 There is no doubt that OB is related to an ...

DUBLIN--(BUSINESS WIRE)--The "Bronchiolitis Obliterans Syndrome Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. Bronchiolitis Obliterans Syndrome (BOS) - ...

A study of lung tissue from patients with end-stage bronchiolitis obliterans syndrome (BOS) as a complication of lung transplantation yielded molecular and morphologic insights into the development of ...

MILAN and BOSTON, May 8, 2023 /PRNewswire/ -- Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve people's health and the quality of patients' lives, today ...

Constrictive bronchiolitis obliterans is an important respiratory illness because of its underlying irreversible fibrotic process, and is defined as concentric fibrosis in the bronchiolar submucosal ...